Digital coaching group Liva Healthcare has raised €24.5m, led by Verlinvest, as it targets expansion into Germany and Benelux states. CEO Andre Sode tells HBI that providers using the tool can better monitor up to five times more patients annually.
As healthcare becomes ever more personalised it’s impacting specialised markets, such as orthopaedics. This piece, authored by Alina Trabattoni, Dr Kristoffer Kenta, and Dr Leonid Shapiro of health and social care consultancy Candesic, reviews how things are evolving in this pan-EU market after speaking to implant manufacturers, surgeons and patients, and reviewing clinical and patient recorded outcomes.
German and Spanish for-profit hospital operator Fresenius Helios has acquired global IVF operator Eugin from in-administration NMC Health, while French number two hospital group Elsan has bought smaller competitor C2S. What does the deal pricing for both say about relative valuations in the two sectors and any COVID impact?
An insurer, an integrated healthcare provider and a telehealth player are three providers with very different experiences of being able to reach the patient. HBI looks at four tangible lessons from Aetna, Medicover and Kry from HBI 2020.
The ability of artificial intelligence to predict life expectancy in oncology is the ‘holy grail’ of the sector. Panellists discussed this and where else AI is having an impact on complex care at HBI 2020.
To a remarkable extent, hospitals CEOs whether in Europe, China or Emerging Markets share the same goals around extending their patient offering forwards into primary and back into chronic and rehabilitation using digital health to achieve this. And the one thing they all know they need to get right is culture.
Most of the ongoing research into healthcare AI is in the clinical space. However, there are plenty of non-clinical tasks, like the protocols and positioning of MRIs, in which AI can boost productivity by 30-50%.
The EBITDA of one of Asia's largest hospital consolidators grew 60% through the COVID-19 pandemic, its executive chairman Vishal Bali said at HBI 2020, as the group "skinned" out a lot of operating costs.
The IFC said at HBI 2020 that medical tourism in emerging markets is unlikely to normalise until the end of 2021. Providers say they are already doubling and tripling plans to build in domestic markets, rather than bringing patients to tourism hubs.
Ping An and Teladoc revealed their plans for global expansion at HBI 2020. The former says it's hard to leave such a big domestic market as China but has sights set on SE Asia and 'the developing world'. Teladoc is focused on Europe, Brazil and also on Ping An's home turf, China! Both are now capable of delivering full acuity care and have driven their insights using some of healthcare's largest datasets.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.